By constructing transgenic mice overexpressing NOX1 in vascular smooth muscle cells (TgSMCnox1), releasing excessive ROS from NOX1 could cause vascular endothelial cell dysfunction, leading to vessel wall hypertrophy and hypertension (41). This evidence concerns the gene NOX1 and hypertensive disorder.